Pretreatment with Eupatilin Attenuates Inflammation and Coagulation in Sepsis by Suppressing JAK2/STAT3 Signaling Pathway

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211.
   PubMed Web of Science ®Google Scholar
• Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016;2:16037.
   PubMed Web of Science ®Google Scholar
• Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131(8):845–854.
   PubMed Web of Science ®Google Scholar
• Rothmeier AS, Marchese P, Petrich BG, et al. Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles. J Clin Invest. 2015;125(4):1471–1484.
   PubMedGoogle Scholar
• Rosseau S, Hammerl P, Maus U, et al. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2000;279(1):L25–35.
   PubMedGoogle Scholar
• Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):58.
   Google Scholar
• Wiersinga WJ. Current insights in sepsis: from pathogenesis to new treatment targets. Curr Opin Crit Care. 2011;17(5):480–486.
   PubMedGoogle Scholar
• Soares MP, Teixeira L, Moita LF. Disease tolerance and immunity in host protection against infection. Nat Rev Immunol. 2017;17(2):83–96.
   PubMedGoogle Scholar
• Mazgaeen L, Gurung P. Recent advances in lipopolysaccharide recognition systems. Int J Mol Sci. 2020;21(2):2. doi:10.3390/ijms21020379
   Web of Science ®Google Scholar
• Cavaillon JM, Adib-Conquy M. Monocytes/macrophages and sepsis. Crit Care Med. 2005;33(12 Suppl):S506–509.
   PubMed Web of Science ®Google Scholar
• Kral-Pointner JB, Schrottmaier WC, Horvath V, et al. Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspiration-induced acute lung injury. J Thromb Haemost. 2017;15(8):1625–1639.
   PubMedGoogle Scholar
• Pawlinski R, Wang JG, Owens AP, et al. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood. 2010;116(5):806–814.
   PubMedGoogle Scholar
• Zhang H, Zeng L, Xie M, et al. TMEM173 drives lethal coagulation in sepsis. Cell Host Microbe. 2020;27(4):556–570.e556.
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 Suppl):S26–34.
   PubMed Web of Science ®Google Scholar
• Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol. 2000;22(4):401–404.
   PubMedGoogle Scholar
• Corral J, Yélamos J, Hernández-Espinosa D, et al. Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Pathol. 2005;166(4):1089–1098.
   PubMedGoogle Scholar
• Zanotti-Cavazzoni SL, Goldfarb RD. Animal models of sepsis. Crit Care Clin. 2009;25(4):703–719, vii–viii.
   Google Scholar
• Nageen B, Sarfraz I, Rasul A, et al. Eupatilin: a natural pharmacologically active flavone compound with its wide range applications. J Asian Nat Prod Res. 2020;22(1):1–16.
   PubMed Web of Science ®Google Scholar
• Lu, X, Deng, T, Dong, H et al. Novel Application of Eupatilin for Effectively Attenuating Cisplatin-Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway. Oxid Med Cell Longev. 2022;2022:1090034.
   PubMedGoogle Scholar
• Yang H, Yang X, Rong K, et al. Eupatilin attenuates the senescence of nucleus pulposus cells and mitigates intervertebral disc degeneration via inhibition of the MAPK/NF-κB signaling pathway. Front Pharmacol. 2022;13:940475.
   PubMedGoogle Scholar
• Jung J, Huh KY, Jin X, et al. A phase I study to evaluate the safety, tolerability, pharmacodynamic and pharmacokinetic profiles of ocular GLH8NDE in healthy male adults. Clin Transl Sci. 2022;15(2):343–352.
   PubMedGoogle Scholar
• Liu H, Hao J, Wu C, et al. Eupatilin alleviates lipopolysaccharide-induced acute lung injury by inhibiting inflammation and oxidative stress. Med Sci Monit. 2019;25:8289–8296.
   PubMedGoogle Scholar
• Bai D, Sun T, Lu F, et al. Eupatilin suppresses OVA-induced asthma by inhibiting NF-κB and MAPK and activating Nrf2 signaling pathways in mice. Int J Mol Sci. 2022;23:3.
   Google Scholar
• Li Y, Ren R, Wang L, Peng K. Eupatilin alleviates airway remodeling via regulating phenotype plasticity of airway smooth muscle cells. Biosci Rep. 2020;40:1.
   Web of Science ®Google Scholar
• Cheong JH, Hong SY, Zheng Y, Noh SH. Eupatilin inhibits gastric cancer cell growth by blocking STAT3-mediated VEGF expression. J Gastric Cancer. 2011;11(1):16–22.
   PubMedGoogle Scholar
• Ryu R, Jung UJ, Kim HJ, et al. Anticoagulant and antiplatelet activities of artemisia princeps pampanini and its bioactive components. Prev Nutr Food Sci. 2013;18(3):181–187.
   PubMedGoogle Scholar
• Xu S, Pan X, Mao L, et al. Phospho-Tyr705 of STAT3 is a therapeutic target for sepsis through regulating inflammation and coagulation. Cell Commun Signal. 2020;18(1):104.
   PubMedGoogle Scholar
• Fang Z, Zhang X, Huang Y, et al. Piperlongumin improves survival in the mouse model of sepsis: effect on coagulation factors and lung inflammation. Inflammation. 2022;1:1–16.
   Google Scholar
• Xiang P, Chen T, Mou Y, et al. NZ suppresses TLR4/NF-κB signalings and NLRP3 inflammasome activation in LPS-induced RAW264.7 macrophages. Inflamm Res. 2015;64(10):799–808.
   PubMedGoogle Scholar
• Toscano MG, Ganea D, Gamero AM. Cecal ligation puncture procedure. J Vis Exp. 2011;51.
   Google Scholar
• Li B, Zeng M, He W, et al. Ghrelin protects alveolar macrophages against lipopolysaccharide-induced apoptosis through growth hormone secretagogue receptor 1a-dependent c-Jun N-terminal kinase and Wnt/β-catenin signaling and suppresses lung inflammation. Endocrinology. 2015;156(1):203–217.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109(22):2698–2704.
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38–44.
   PubMed Web of Science ®Google Scholar
• Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 1991;30(43):10363–10370.
   PubMed Web of Science ®Google Scholar
• Witkowski M, Landmesser U, Rauch U. Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med. 2016;26(4):297–303.
   PubMed Web of Science ®Google Scholar
• Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol. 2018;38(4):709–725.
   PubMed Web of Science ®Google Scholar
• Zelaya H, Rothmeier AS, Ruf W. Tissue factor at the crossroad of coagulation and cell signaling. J Thromb Haemost. 2018;16(10):1941–1952.
   PubMedGoogle Scholar
• Egorina EM, Sovershaev MA, Bjørkøy G, et al. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol. 2005;25(7):1493–1498.
   PubMed Web of Science ®Google Scholar
• McVey JH. The role of the tissue factor pathway in haemostasis and beyond. Curr Opin Hematol. 2016;23(5):453–461.
   PubMedGoogle Scholar
• Yang X, Cheng X, Tang Y, et al. Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure. Immunity. 2019;51(6):983–996.e986.
   PubMedGoogle Scholar
• van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med. 1994;179(4):1253–1259.
   PubMed Web of Science ®Google Scholar
• Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol. 1989;9(6):2752–2755.
   PubMed Web of Science ®Google Scholar
• Franco RF, de Jonge E, Dekkers PE, et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood. 2000;96(2):554–559.
   PubMedGoogle Scholar
• Aras O, Shet A, Bach RR, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood. 2004;103(12):4545–4553.
   PubMed Web of Science ®Google Scholar
• Pawlinski R, Pedersen B, Schabbauer G, et al. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood. 2004;103(4):1342–1347.
   PubMedGoogle Scholar
• Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood. 1999;94(10):3413–3420.
   PubMed Web of Science ®Google Scholar
• Amaral A, Opal SM, Vincent JL. Coagulation in sepsis. Intensive Care Med. 2004;30(6):1032–1040.
   PubMed Web of Science ®Google Scholar
• Conway EM. Thrombin: coagulation’s master regulator of innate immunity. J Thromb Haemost. 2019;17(11):1785–1789.
   PubMedGoogle Scholar
• Mosesson MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol. 1992;29(3):177–188.
   PubMedGoogle Scholar
• Spronk HM, van der Voort D, Ten Cate H. Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J. 2004;2(1):12.
   PubMedGoogle Scholar
• Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest. 2005;128(4):2864–2875.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Wada H, Watanabe Y, et al. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. Thromb Res. 2001;104(1):1–6.
   PubMedGoogle Scholar
• Bode JG, Albrecht U, Häussinger D, Heinrich PC, Schaper F. Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling. Eur J Cell Biol. 2012;91(6–7):496–505.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhao H, Wang P, Wang J, Zou L. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases. Scand J Immunol. 2018;88(6):e12727.
   PubMedGoogle Scholar
• Zimmers TA, Fishel ML, Bonetto A. STAT3 in the systemic inflammation of cancer cachexia. Semin Cell Dev Biol. 2016;54:28–41.
   PubMedGoogle Scholar
• Zhao J, Yu H, Liu Y, et al. Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2016;311(5):L868–l880.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung Y, Kim SN. Identification of Eupatilin from Artemisia argyi as a Selective PPARα Agonist Using Affinity Selection Ultrafiltration LC-MS. Molecules. 2015;20(8):13753–13763.
   PubMedGoogle Scholar
• Fei X, Chen C, Kai S, et al. Eupatilin attenuates the inflammatory response induced by intracerebral hemorrhage through the TLR4/MyD88 pathway. Int Immunopharmacol. 2019;76:105837.
   PubMedGoogle Scholar
• Lee DC, Oh JM, Choi H, et al. Eupatilin inhibits reactive oxygen species generation via Akt/NF-κB/MAPK signaling pathways in particulate matter-exposed human bronchial epithelial cells. Toxics. 2021;9:2.
   Google Scholar
• Choi EJ, Lee S, Chae JR, Lee HS, Jun CD, Kim SH. Eupatilin inhibits lipopolysaccharide-induced expression of inflammatory mediators in macrophages. Life Sci. 2011;88(25–26):1121–1126.
   PubMedGoogle Scholar